The SPC blog

A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Monday, 19 January 2009

Gilead article just published in BioSLR

"Extension granted: Gilead obtains its SPC for Combination Antiretrovirals" is the name of the atricle by Jonathan Ball (Norton Rose) which has just been published in vol.9, issue 5, of the Bioscience Law Review. 

This journal, published six times a year by Lawtext, welcomes articles and case notes on all areas of bioscience law and practice, including supplementary protection certificates. You can read Jonathan Ball's note in full by clicking here.




Posted by Jeremy at 5:52 am
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)